JonDeTech Sensors (JDT) Q2 2026 earnings summary
Event summary combining transcript, slides, and related documents.
Q2 2026 earnings summary
27 Jul, 2026Executive summary
Achieved first commercial agreement with Japanese partners, marking a key milestone in transition to a commercial sensor company focused on digital health.
Commercial pipeline expanded, with over 20 active customer projects in wearables, digital health, and industrial applications.
Financing secured through a rights issue and loan facility to support sensor production and delivery for new contracts.
Financial highlights
Q2 2026 net sales rose to 58 tkr from 5 tkr year-over-year; H1 2026 net sales reached 111 tkr.
Q2 2026 EBITDA was -4,901 tkr, down 9% year-over-year; EBIT was -8,084 tkr.
Net result for Q2 2026 was -8,901 tkr, compared to -8,173 tkr in Q2 2025.
Cash flow from operations in Q2 2026 was 5,548 tkr, a significant improvement from -4,257 tkr in Q2 2025.
Cash at period end was 302 tkr; equity ratio at 63%.
Outlook and guidance
No major R&D investments planned for 2026 as technology has matured; focus shifts to commercial activities and customer project completion.
Full subscription of TO5 options in late 2026 could provide an additional 24.8 MSEK, expected to fund operations through 2027.
Latest events from JonDeTech Sensors
- Commercialization focus improved margins and expanded customer pipeline in wearables.JDT
Q1 2026 - Q4 2025 saw higher revenue and commercial momentum, but losses persisted amid scaling efforts.JDT
Q4 2025 - Q3 2025 saw revenue growth, new product launches, and a completed rights issue amid ongoing losses.JDT
Q3 2025 - Order backlog up 52% and cost base down 27% as commercialization accelerates.JDT
Q2 2025 - Q3 2024 saw revenue growth, improved EBITDA, and strong new financing for future expansion.JDT
Q3 2024 - Revenue and order backlog surged as cost reductions and Asian partnerships drive growth.JDT
Q2 2024 - EBITDA loss halved and global reach expanded, but external funding remains critical.JDT
Q1 2025 - Order backlog surged and losses narrowed as JonDeTech accelerates commercialization.JDT
Q4 2024